BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 31534119)

  • 1. Dynasore suppresses cell proliferation, migration, and invasion and enhances the antitumor capacity of cisplatin via STAT3 pathway in osteosarcoma.
    Zhong B; Shi D; Wu F; Wang S; Hu H; Cheng C; Qing X; Huang X; Luo X; Zhang Z; Shao Z
    Cell Death Dis; 2019 Sep; 10(10):687. PubMed ID: 31534119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternol, a natural compound, exerts an anti-tumour effect on osteosarcoma by modulating of STAT3 and ROS/MAPK signalling pathways.
    Zuo D; Zhou Z; Wang H; Zhang T; Zang J; Yin F; Sun W; Chen J; Duan L; Xu J; Wang Z; Wang C; Lin B; Fu Z; Liao Y; Li S; Sun M; Hua Y; Zheng L; Cai Z
    J Cell Mol Med; 2017 Feb; 21(2):208-221. PubMed ID: 27624867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stattic sensitizes osteosarcoma cells to epidermal growth factor receptor inhibitors via blocking the interleukin 6-induced STAT3 pathway.
    Wang S; Wang Y; Huang Z; Wei H; Wang X; Shen R; Lan W; Zhong G; Lin J
    Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1670-1680. PubMed ID: 34693451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
    Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
    Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells.
    Yang Q; Zhang S; Kang M; Dong R; Zhao J
    Oncol Rep; 2015 May; 33(5):2537-44. PubMed ID: 25738402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zoledronic Acid Enhanced the Antitumor Effect of Cisplatin on Orthotopic Osteosarcoma by ROS-PI3K/AKT Signaling and Attenuated Osteolysis.
    Liu L; Geng H; Mei C; Chen L
    Oxid Med Cell Longev; 2021; 2021():6661534. PubMed ID: 33859780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G721-0282 inhibits cell growth and induces apoptosis in human osteosarcoma through down-regulation of the STAT3 pathway.
    Park KR; Yun HM; Hong JT
    Int J Biol Sci; 2020; 16(2):330-341. PubMed ID: 31929760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
    Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
    Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glaucocalyxin A-induced oxidative stress inhibits the activation of STAT3 signaling pathway and suppresses osteosarcoma progression in vitro and in vivo.
    Mao M; Zhang T; Wang Z; Wang H; Xu J; Yin F; Wang G; Sun M; Wang Z; Hua Y; Cai Z
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1214-1225. PubMed ID: 30659925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3.
    Zheng B; Ren T; Huang Y; Guo W
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1695-1701. PubMed ID: 29225166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liensinine Inhibits Osteosarcoma Growth by ROS-Mediated Suppression of the JAK2/STAT3 Signaling Pathway.
    Jia F; Liu Y; Dou X; Du C; Mao T; Liu X
    Oxid Med Cell Longev; 2022; 2022():8245614. PubMed ID: 35116094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasome Inhibitor MG132 Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells and Inhibits Tumor Growth.
    Sun F; Zhang Y; Xu L; Li S; Chen X; Zhang L; Wu Y; Li J
    Oncol Res; 2018 May; 26(4):655-664. PubMed ID: 29191257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloroquine suppresses proliferation and invasion and induces apoptosis of osteosarcoma cells associated with inhibition of phosphorylation of STAT3.
    Chen C; Zhang H; Yu Y; Huang Q; Wang W; Niu J; Lou J; Ren T; Huang Y; Guo W
    Aging (Albany NY); 2021 Jun; 13(13):17901-17913. PubMed ID: 34170850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardamonin inhibits the growth of human osteosarcoma cells through activating P38 and JNK signaling pathway.
    Zhang L; Yang C; Huang Y; Huang H; Yuan X; Zhang P; Ye C; Wei M; Wang Y; Luo X; Luo J
    Biomed Pharmacother; 2021 Feb; 134():111155. PubMed ID: 33370628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tanshinone I inhibits the growth and metastasis of osteosarcoma via suppressing JAK/STAT3 signalling pathway.
    Wang W; Li J; Ding Z; Li Y; Wang J; Chen S; Miao J
    J Cell Mol Med; 2019 Sep; 23(9):6454-6465. PubMed ID: 31293090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic inhibitory effects of capsaicin combined with cisplatin on human osteosarcoma in culture and in xenografts.
    Wang Y; Deng X; Yu C; Zhao G; Zhou J; Zhang G; Li M; Jiang D; Quan Z; Zhang Y
    J Exp Clin Cancer Res; 2018 Oct; 37(1):251. PubMed ID: 30326933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C₁₈H₁₇NO₆ Inhibits Invasion and Migration of Human MNNG Osteosarcoma Cells via the PI3K/AKT Signaling Pathway.
    Qu Q; He Z; Jiang Y; Lu D; Long X; Ding Y; Xu B; He X
    Med Sci Monit; 2019 Oct; 25():7527-7537. PubMed ID: 31589596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the Notch signaling pathway attenuates progression of cell motility, metastasis, and epithelial-to-mesenchymal transition-like phenomena induced by low concentrations of cisplatin in osteosarcoma.
    Dai G; Liu G; Zheng D; Song Q
    Eur J Pharmacol; 2021 May; 899():174058. PubMed ID: 33757752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynasore suppresses proliferation and induces apoptosis of the non-small-cell lung cancer cell line A549.
    Shen F; Gai J; Xing J; Guan J; Fu L; Li Q
    Biochem Biophys Res Commun; 2018 Jan; 495(1):1158-1166. PubMed ID: 29175207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrine enhances the efficacy of adriamycin chemotherapy in osteosarcoma cells by the STAT3 pathway.
    Zhou H; Chen S; Yang Y; Yang C; Chen D; Yao Z; Sun B
    Anticancer Drugs; 2019 Nov; 30(10):1006-1012. PubMed ID: 31609759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.